Adam Ertel, PhD

Contact Dr. Ertel

233 South 10th Street
BLSB 1009
Philadelphia, PA 19107

(215) 503-7452
(215) 503-9142 fax

Most Recent Peer-reviewed Publications

  1. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth
  2. Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy
  3. The chemokine receptor CXCR3 promotes CD8+t cell accumulation in uninfected salivary glands but is not necessary after murine cytomegalovirus infection
  4. Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome
  5. Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer
  6. Cell cycle-coupled expansion of AR activity promotes cancer progression
  7. Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages
  8. RB loss promotes prostate cancer metastasis
  9. Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
  10. v-Src oncogene induces Trop2 proteolytic activation via cyclin D1
  11. Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injury
  12. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  13. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a CXCL signaling module
  14. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer
  15. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the connectivity map database
  16. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
  17. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  18. A community computational challenge to predict the activity of pairs of compounds
  19. A community effort to assess and improve drug sensitivity prediction algorithms
  20. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness